International Journal of Scientific Research and Engineering Development

Nadolol is a beta-blocker that affects the heart and circulation, helping to lower blood pressure by reducing heart rate and workload. Bendroflumethiazide is a thiazide diuretic that helps prevent the body from absorbing too much salt, which can cause fluid retention. The combination of these two medications works synergistically to lower blood pressure and reduce the risk of heart-related complications. Nadolol and Bendroflumethiazide combination is used to treat high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also increase the risk of heart attacks. These problems may be less likely to occur if blood pressure is controlled